Search

everythinglearnresearchcommunity

for

Search:↓

A microneedle patch with curcumin and stem cell components effectively treats hypertrophic scars and promotes healing.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

CRISPR/Cas9 gene-editing shows promise for improving sheep and goat breeding but faces challenges with efficiency and accuracy.

The first Japanese family with Marie Unna hereditary hypotrichosis showed hair condition improvement in a child and highlighted the risk of misdiagnosis.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Medications for PCOS don't seem to raise heart disease risk.

Keratins are crucial for cell structure, growth, and disease risk.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Doctors should recognize and treat PCOS early in primary care to manage symptoms and lower risk of other health issues.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Endocrine-disrupting chemicals cause irreversible harm to children's development, increasing disease risk.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Many dermatologists in Saudi Arabia recommend vitamins and minerals for hair loss, often based on personal experience rather than strong evidence.